Beijing GoBroad Hospital
北京高博医院
Beijing GoBroad Hospital is a leading private research-oriented hospital and flagship institution of the GoBroad Healthcare Group, established in 2017. Located in Changping Life Science Park, Beijing, the hospital officially opened in July 2023 and specializes in solid tumors, hematologic tumors, and brain science. It is renowned as one of China's top centers for CAR-T cell immunotherapy and hematopoietic stem cell transplantation (bone marrow transplant), treating patients with lymphoma, myeloma, leukemia, and other challenging hematologic cancers. The hospital integrates clinical research, precision diagnostics, and innovative cellular therapies, with more than half of its team dedicated to clinical innovation. For international patients from 12+ countries, the hospital operates a dedicated International Patient Service Center providing end-to-end support including medical visa guidance, airport transfers, multilingual coordination, and international insurance assistance, achieving a 95% patient satisfaction rate.
Departments
Key departments
The Hematology & Oncology Center is the hospital's flagship department, led by experts in CAR-T cell therapy and bone marrow transplantation, treating leukemia, lymphoma, myeloma, and thalassemia with cutting-edge immunotherapy protocols. The Solid Tumor Center provides comprehensive multidisciplinary care for gastrointestinal, thoracic, urologic, and melanoma cancers, integrating precision targeted therapy and clinical trials of innovative drugs. The Brain Science Department focuses on neurodegenerative diseases including Parkinson's disease, utilizing novel therapeutic approaches. The Clinical Research Center serves as a public service platform for clinical research in Beijing, having partnered with hundreds of innovative pharmaceutical companies to conduct numerous clinical trials.
Procedures and equipment
Beijing GoBroad Hospital is at the forefront of cellular therapy and transplant medicine. The hospital excels in CAR-T cell immunotherapy for relapsed/refractory B-cell lymphoma, achieving remarkable remission rates in patients who have failed conventional treatments. Its hematopoietic stem cell transplantation (HSCT) program, combining autologous transplant with CAR-T therapy, has demonstrated significantly improved progression-free survival for aggressive lymphomas and central nervous system lymphomas. The hospital also pioneers radionuclide therapy with four dedicated treatment wards serving 200+ patients annually, and performs advanced minimally invasive interventional oncology procedures for solid tumors including liver cancer and lung cancer.
International patient services
Contact
- Address:
- Building 1, No.4 Science Park Road, Life Science Park, Changping District, Beijing, China
- Phone:
- +86-400-696-2000
- Hours:
- Mon-Fri 8:00AM-5:00PM
Content source & reuse
This profile is compiled from the hospital's public information and the CHINAMEDLINK hospital directory (data dated 2026-05-06). It has not been independently verified by us — confirm details with the hospital before seeking care.
- Canonical source
- https://260929-chinese-hospital.vercel.app/en/hospitals/beijing-gobroad-hospital-beijing
This page is for information and referral purposes only. It is not medical advice, diagnosis or treatment, and does not replace an in-person consultation. Verify anything critical directly with the provider before seeking care. Medical disclaimer · Terms of service